New eye drops show promise for dry eye sufferers in early trial
NCT ID NCT06792903
First seen Mar 23, 2026 · Last updated Jun 15, 2026 · Updated 15 times
Summary
This early-stage study tested YM-101 eye drops in 30 adults with dry eye syndrome. Participants received either the active drops or a placebo, and then switched after a period. The main goals were to see if the drops improved eye surface health (measured by corneal staining) and to check for side effects. The study also looked at tear stability and symptom questionnaires.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Eye & ENT hospital of Fudan University
Shanghai, Shanghai Municipality, 20031, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.